Publication:
A PPAR-alpha agonist gemfibrozil ameliorates cognitive and memory impairments in a sporadic Alzheimer's disease rat

dc.contributor.authorYAVUZ, AYŞE NUR
dc.contributor.authorKABASAKAL, LEVENT
dc.contributor.authorÇAM, MUHAMMET EMİN
dc.contributor.authorsYildiz, S.; Cam, M. E.; Keles, R.; Hazar-Yavuz, A. N.; Kabasakal, L.
dc.date.accessioned2022-03-12T16:24:17Z
dc.date.accessioned2026-01-11T08:17:28Z
dc.date.available2022-03-12T16:24:17Z
dc.date.issued2019
dc.identifier.doi10.1016/j.euroneuro.2018.11.419
dc.identifier.eissn1873-7862
dc.identifier.issn0924-977X
dc.identifier.urihttps://hdl.handle.net/11424/226290
dc.identifier.wosWOS:000458400500357
dc.language.isoeng
dc.publisherELSEVIER
dc.relation.ispartofEUROPEAN NEUROPSYCHOPHARMACOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleA PPAR-alpha agonist gemfibrozil ameliorates cognitive and memory impairments in a sporadic Alzheimer's disease rat
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageS264
oaire.citation.startPageS263
oaire.citation.titleEUROPEAN NEUROPSYCHOPHARMACOLOGY
oaire.citation.volume29

Files